A global diagnostics company accelerated FDA approval and market launch for 12 infectious disease tests by partnering with Boca Bio. Facing delays from slow, inflexible vendors, the company needed rapid sample sourcing, faster testing, and agile clinical support. Boca Bio delivered results up to 12x faster, reduced site activation timelines by half, and ensured compliance with strict FDA deadlines—enabling earlier market entry and improved revenue outcomes.

Accelerate vaccine development with rapid serum procurement from recently immunized subjects. Boca Biolistics provides high-quality, well-characterized serum samples with fast turnaround times, scalable recruitment, and comprehensive clinical metadata. Supporting vaccine trials and immunogenicity studies, our CLIA- and CAP-certified biorepository ensures compliance with HIPAA and 21 CFR Part 11 standards. Generate reliable immune response data within critical post-immunization windows and advance biomarker analysis, vaccine benchmarking, and clinical research outcomes.